Fusion event
HBV-RPL23AP82 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CTATTTACACACTCTATGGAAGGCGGGTATATTATATAAGAGAGAAACAACACATAGCGCCTCATTTTGTGGGTCACCATATTCTTGGGAACAAGATCTA| |CAGCATGGGGCAGAATCTTTCCACCAGCAATCCTCTGGGATTCTTTCCCGACCACCAGTTGGATCCAGCCTTCAGAGCAAACACCGCAAATCCAGATTGG
End
51229347/50790919 (Hg38)
Location type
ncRNA_intronic
Nearest miRNA
hsa-let-7a-3/Upstream/383395;
Upstream sequence
GCCATACCACTCAGAGGGAATGCAATACATATTGACATCTCCTTTAGGATGTCCATAGAGAATTCAAGAAAAGAAATAATTTAAAAGTGCTTTTGGGTAC
Downstream sequence
AGCTATTTAGCACTAGAGGGTAAGAGTAGAGATAGATTGTAAAGATAATAAtagggttaggcataggattaggatctgggtcagagtcagggccggaagt
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.